ArticleCureus2026
Benchmarking Drug Library Compliance and Alert Rates in Smart Infusion Pumps: A Multicenter Retrospective Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSmart infusion pumps with dose error-reduction software (DERS) generate alerts to prevent infusion programming errors. However, high alert volumes may contribute to alert fatigue and impact workflow efficiency. Benchmarking continuous quality improvement (CQI) data across institutions may help identify opportunities to optimize drug library (DL) performance. This study evaluated the relationship between DL compliance and alert-related metrics using a benchmarking approach.
methodsA retrospective multicenter analysis of smart infusion pump data was conducted across 90 institutions (99 data pulls), including 13,749,759 infusions. Key metrics included DL compliance, alert rate, override rate, and alerts resulting in reprogramming ("good catches"). Facilities with DL compliance <95% and ≥95% were compared, and Spearman correlation analyses were performed to assess associations between DL compliance and alert-related outcomes.
resultsThe overall DL compliance rate was 95.9%. The mean alert rate was 33.3% (±12.20), and the overall override rate was 96.4%. On average, one good catch occurred for every 34.5 DERS infusions. Benchmarking across institutions showed no statistically significant differences in alert rates, override rates, or good catch rates between facilities with DL compliance ≥95% and those with <95%. Correlation analyses demonstrated only weak associations between DL compliance and alert rate, override rate, and good catch metrics.
conclusionsBenchmarking CQI data across institutions demonstrates that high DL compliance alone does not necessarily indicate optimized smart infusion pump performance. Incorporating alert and override metrics into CQI analyses may help reduce non-actionable alert burden and support safer, more efficient infusion workflows.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.